Received 3 October 2012
Production, crystallization and X-ray diffraction analysis of two nanobodies against the Duffy binding-like (DBL) domain DBL6-FCR3 of the Plasmodium falciparum VAR2CSA protein. Corrigendum
Anneleen Vuchelen,a,b Els Pardon,a,b Jan Steyaert,a,b Benoît Gamain,c,d,e,f Remy Loris,a,b* Nico A. J. van Nulanda,b and Stéphanie Ramboarinaa,b*
aStructural Biology Brussels, Department of Biotechnology (DBIT), Vrije Universiteit Brussel, Pleinlaan 2, B-1050 Brussels, Belgium,bMolecular Recognition Unit (MoRe), Department of Structural Biology, VIB, Pleinlaan 2, B-1050 Brussels, Belgium,cInserm, UMRS665, F-75015 Paris, France,dUniversité Paris Diderot, F-75013 Paris, France,eInstitut National de la Transfusion Sanguine, F-75015 Paris, France, and fLaboratoire d'Excellence Gr-Ex, France
A correction is made to Fig. 1 and the text of the article by Vuchelen et al. (2013, Acta Cryst. F69, 270-274) .
In the article by Vuchelen et al. (2013) there is a mistake in Fig. 1. The second line of Nb19 is a copy of the second line of Nb07, instead of the correct Nb19 line. This results in a difference of four amino acids. In §3, it is mentioned that there is one amino-acid substitution between the two nanobodies but this should be five (to include the four from the second line). Also the sequence identity should be 94% instead of 98%. A correct version of Fig. 1 is published here.
| || Figure 1 |
Corrected sequence alignment of Nb2907 and Nb2919. The complementary determining regions (CDR) are shown in red boxes.